Exenatide Completed Phase 4 Trials for Polycystic Ovarian Syndrome (PCOS) / Overweight and Obesity / Disorder of Glucose Regulation Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03352869Research of Exenatide for Overweight/Obese PCOS Patients With IGR